What is VALGEN™?

Value Addition Through Genomics and GE3LS

The well-being of Canadians has long depended upon the agricultural industry. The VALGEN™ research team is investigating how Canada can benefit from applications of agricultural genomics, a new science which studies the effects of the entire set of genes making up a particular organism such as our familiar crops of wheat, flax, canola and corn. The project focuses on three crucial factors that affect how scientific discoveries make their way from laboratory to the marketplace.

Research Themes

Thumb

Democratic Engagement

Canadians need meaningful ways to participate in decision-making about how we choose, develop and use new agricultural technologies and products.  The VALGEN team will engage the Canadian public to learn...

Thumb

Governance and Regulation

VALGEN aims to identify new models for governance of breakthrough agricultural technologies and bioproducts, and to ensure that publicly supported research is used efficiently to benefit Canadians. For Canadians to get...

Thumb

Intellectual Property Management and Technology Transfer

VALGEN will examine how scientific and technological discoveries leave the laboratory as intellectual property such as patents, copyrights and trade secrets.  The research will investigate how these legal tools are...

Thumb

VALGEN’s Toolbox: Triage, Models, Methods, and Metrics

VALGEN’s Toolbox: Triage, Models, Methods, and Metrics Triage: VALGEN will apply a triage methodology to consolidate resources and set priorities. Triage will consider known versus unknown theory and evidence and...

Recent News

Handbook on Agriculture, Biotechnology and Development

Discover evidence of economic and social impacts of agricultural biotechnology, drawing on expert perspectives of 50 leading authors from 48 different institutions in 18 countries. ...

Policy Brief – Impacts on Biodiversity and Biosafety Regulatory Frameworks

Policy Brief #49 offers an assessment of biodiversity as addressed by Article 26 of the Cartagena Protocol on Biosafety. Article 26 has been interpreted in many different ways, resulting in inconsistent...

Policy Brief – Socio-Economic Considerations in Biotechnology Regulation

Policy Brief #48 introduces the debate over socio-economic considerations in the biosafety regulatory framework. Read the brief here....

Read more news...